What is BGLC's gross margin?

BioNexus (BGLC) has a gross margin of 17% and a net margin of -376%.

What is BGLC's P/E ratio?

Track BioNexus (BGLC) P/E ratio, ROE, and valuation metrics over time.

Where can I see BGLC's full financials?

See BioNexus (BGLC) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioNexus (BGLC) Financials — Revenue, Earnings, Cash Flow

$1.27

+0.07 (+5.83%)

Weekly Expected Move ±9.4%

$1 $1 $1 $1 $1

NASDAQ · Industrials · Industrial - Distribution · Tech Score Sell · Power 26 · $3.1M mcap · 2M float · 4.72% daily turnover · Short 34% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$3M

Revenue

-67.3% YoY

$-3M

Net Income

+12.2% YoY

$-1M

Free Cash Flow

+73.4% YoY

17.0%

Gross Margin

-370.8%

Op. Margin

-376.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-33.7%

ROA-28.4%

ROIC-45.9%

Valuation

P/E-1.0

P/B0.4

EV/EBITDA-0.6

Leverage

Debt/Equity0.03

Current Ratio6.08

Interest Cov.-404.1x

Quality Scores

Piotroski F4/9

Altman Z1.77

Beneish M-3.87